CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for NMT Medical, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

NMT Medical, Inc.
27 Wormwood St
Phone: (617) 737-0930p:617 737-0930 BOSTON, MA  02210-1619  United States Fax: (617) 737-0924f:617 737-0924

On 5/1/2014, the U.S. Securities and Exchange Commission revoked the registration of each class of registered securities of NMT Medical, Inc. for failure to make required periodic filings with the Commission.

Business Summary
NMT Medical, Inc. is a medical technology company that designs, develops, manufactures and markets implant technologies that enables interventional cardiologists to treat structural heart disease, through catheter-based procedures. During the year ended December 31, 2009, the Company’s revenues were derived from sales of its CardioSEAL, STARFlex and BioSTAR products primarily in the United States, Europe and Latin America. It also re-sells third party products for use with the CardioSEAL, STARFlex and BioSTAR implant devices, vascular sizing balloons and sheaths. BioSTAR is the Company’s bioabsorbable patent foramen ovale (PFO) implant and the biological closure technology. The Company manufactures the CardioSEAL, STARFlex and BioSTAR cardiac septal repair implants at its headquarters in Boston, Massachusetts. Its customers include hospitals, clinics and other healthcare centers.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
-Yes-------

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201012/31/2009YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, President, Chief Executive Officer Richard E.Davis 55 8/26/2010 8/1/2000
Director John E.Ahern 67 3/3/2010 9/25/2000
Director Daniel F.Hanley 62 5/7/2003 5/7/2003
Director Paul H.Kramer 61 5/19/2010 5/19/2010
Director David L.West 65 7/12/2007 7/12/2007

Business Names
Business Name
Nitinol Medical Technologies FSC, Inc.
NMT Heart, Inc.
NMT Investments Corp.
4 additional Business Names available in full report.

General Information
Number of Employees: 77 (As of 12/31/2009)
Outstanding Shares: 16,020,069 (As of 11/5/2010)
Shareholders: 100
Stock Exchange: OTC
Federal Tax Id: 954090463
Fax Number: (617) 737-0924


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, August 18, 2019